Intra-host SARS-CoV-2 single-nucleotide variants emerged during the early stage of COVID-19 pandemic forecast population fixing mutations.
Yi Zhang, Ning Jiang, Weiqiang Qi, Tao Li, Yumeng Zhang, Haocheng Zhang, Jing Wu, Zhaoqin Zhu, Jingwen Ai, Chao Qiu, Wenhong Zhang
Author Information
- Yi Zhang: Department of Infectious Diseases, National Clinical Research Center for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China.
- Ning Jiang: Department of Infectious Diseases, National Clinical Research Center for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering and Institute of Biostatistics, School of Life Sciences, Fudan University, Shanghai, China.
- Weiqiang Qi: Shanghai Public Health Clinical Center, Shanghai, China.
- Tao Li: Shanghai Public Health Clinical Center, Shanghai, China.
- Yumeng Zhang: Department of Infectious Diseases, National Clinical Research Center for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China.
- Haocheng Zhang: Department of Infectious Diseases, National Clinical Research Center for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China.
- Jing Wu: Department of Infectious Diseases, National Clinical Research Center for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China.
- Zhaoqin Zhu: Shanghai Public Health Clinical Center, Shanghai, China. Electronic address: zhaoqinzhu@163.com.
- Jingwen Ai: Department of Infectious Diseases, National Clinical Research Center for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China. Electronic address: jingwenai1990@126.com.
- Chao Qiu: Department of Infectious Diseases, National Clinical Research Center for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China; Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: qiuchao@fudan.edu.cn.
- Wenhong Zhang: Department of Infectious Diseases, National Clinical Research Center for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China; Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China; State Key Laboratory of Genetic Engineering and Institute of Biostatistics, School of Life Sciences, Fudan University, Shanghai, China; Key Laboratory of Medical Molecular Virology (MOE/MOH), Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: zhangwenhong@fudan.edu.cn.
No abstract text available.
- Clin Microbiol Infect. 2020 Nov;26(11):1560.e1-1560.e4
[PMID: 32717416]
- Genome Med. 2021 Feb 22;13(1):30
[PMID: 33618765]
- Genomics Proteomics Bioinformatics. 2020 Dec;18(6):749-759
[PMID: 33704069]
- Science. 2021 Apr 16;372(6539):
[PMID: 33688063]
- Sci Adv. 2020 Jun 17;6(25):eabb5813
[PMID: 32596474]
- J Infect. 2020 Sep;81(3):e48-e50
[PMID: 32593658]
- Science. 2021 Feb 19;371(6531):850-854
[PMID: 33495308]
- Nat Microbiol. 2016 Sep 05;1(11):16151
[PMID: 27595345]
- Nat Rev Microbiol. 2021 Jul;19(7):409-424
[PMID: 34075212]
COVID-19
Genome, Viral
Humans
Mutation
Nucleotides
Pandemics
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Nucleotides
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2